Close Menu

Chronic Myeloid Leukaemia

Five Year Follow-up of Patients Treated with Imatinib Mesylate for Chronic Myeloid Leukaemia in Trinidad and Tobago

Issue: 
Pages: 
298–302
Synopsis: 
The delivery of quality pharmacy services is thought to be important by virtue of its influence on patient’s satisfaction and hence better patient compliance/adherence. This study explores the relationship between patient’s satisfaction with pharmacy services and control of selected chronic diseases. General Hospital is presented. Efficacy, safety and tolerability seem comparable to that reported in developed countries.

ABSTRACT

Objective: Data on the use of Imatinib (IM) in developing countries remain limited. A retrospective study was done to assess the efficacy and toxicity of IM in treating chronic myeloid leukaemia (CML) in Trinidad and Tobago.

PDF Attachment: 
Journal Sections: 
e-Published: 31 Jan, 2014

Chronic Myeloid Leukaemia at the University Hospital of the West Indies: a 17 Year Review

Issue: 
Pages: 
493–6

ABSTRACT

Objective: To determine the presenting features and evolution of patients diagnosed with chronic myeloid leukaemia between 1983 and 1999 at the University Hospital of the West Indies.

Methods: Forty-one records were retrospectively analyzed for the patients’ demographics, reasons for referral, clinical features, laboratory investigations and the time to blast transformation and death.

PDF Attachment: 
Journal Sections: 
e-Published: 24 Jul, 2013
Subscribe to RSS - Chronic Myeloid Leukaemia
Top of Page